ST
STE
Quarter ended Sep 30, 2025 · FY2026 Q2

STERIS (STE) Revenue — Quarter Ended Sep 30, 2025

Revenue for the reporting quarter increased. The growth was consistent with the trend seen in recent periods.

Key takeaway

Quarter ended Sep 30, 2025 · FY2026 Q2

Revenue for the reporting quarter increased. The growth was consistent with the trend seen in recent periods.

Financial snapshot

Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.

Quarter revenue

$1.5B

Revenue reported for this quarter.

Quarter-over-quarter

+5.0%

Change from the immediately preceding quarter.

Year-over-year

+9.9%

Change from the comparable year-ago quarter.

Trailing four quarters

$5.7B

Sum of the latest four reported quarters.

Quarterly revenue trend

The latest four reported quarters with year-over-year comparisons.

Period endedRevenueYear-over-year change
Dec 31, 2024$1.4B+5.6%
Mar 31, 2025$1.5B+4.3%
Jun 30, 2025$1.4B+8.7%
Sep 30, 2025$1.5B+9.9%

Revenue performance

Revenue rose compared to the prior quarter and was higher than the same quarter a year ago.

Quarterly comparison

The sequential increase followed a similar magnitude as the prior quarter's change. The year-over-year gain was larger than the previous quarter's year-over-year gain.

What to watch

The year-over-year revenue growth rate has accelerated for the past two quarters.

STERIS (STE) Revenue — Quarter Ended Sep 30, 2025